cAMP Gi kit HTRF®

This HTRF kit detects changes of cAMP accumulation in response to Gi coupled GPCR activation or inhibition

See more
  • Ease-of-use Ease-of-use
  • High sensitivity High sensitivity
  • Accurate pharmacology Accurate pharmacology

This HTRF kit detects changes of cAMP accumulation in response to Gi coupled GPCR activation or inhibition



Based on HTRF technology, the kit contains all the reagents needed to quantify cAMP, ensuring that you benefit from a complete tool for your needs.

Cisbio's cAMP kits are best suited for measuring cAMP modulations in response to Gi-activation, leveraging an optimized combination of robustness and sensitivity.



Assay principle

cAMP kits are based on a competitive format involving a specific antibody labeled with d2 (acceptor) and cAMP coupled to cryptate (donor). This enables the direct characterization of all types of compounds acting on Gi-coupled receptors in either adherent or suspension cells. Native cAMP produced by cells competes with cryptate -labeled cAMP for binding to monoclonal anti-cAMP.
Diagram of cAMP Gi assay principle

Assay protocol

The protocol is simple and straightforward, with just two incubation steps: - Cell stimulation by the target compounds - cAMP detection using HTRF reagents
Diagram of cAMP Gi assay prrotocol

Product specifications

Designed with signal performance in mind, the kit offers a tailored standard curve ideally suited to the study of Gi coupled GPCRs.

S/BIC10 nMIC50 nMIC90 nM
cAMP - Gi>310.83.012
cAMP Gi standard curve characteristics

Introduction to product validation

The cAMP Gi kit allows enhanced performances for Gi coupled receptor assessment.

The data below shows the pharmacological validation of the Gi kit for the stably expressing delta opioid receptor cell line. Agonists and antagonists were well characterized, showing potency in agreement with the literature.

Validation on agonist dose response

​CHO cells stably expressing the delta opioid receptor (DOR) at 6000 cells/well were treated with the SNC-162, a reference agonist, for 45 min.

SNC-162 was well characterized, displaying the right potency in good correlation with the literature.​

DOR Agonist SNC-162
cAMP GicAMP Gs dynamic
Optimal Cell density / well600012000
EC50 (nM)1.61.9
SNC-162 agonist dose response on the Delta Opoid receptor

Validation on antagonist dose response

CHO cells stably expressing the delta opioid receptor (DOR) at 6000 cells/well were treated with the SNC-162 agonist for 45 min at the EC90 value (10 nM), which is the optimal concentration to use for the antagonist mode experiment.

Fitting the serial dilutions of the Naltrindole and the Naloxone antagonists enabled IC50 calculation of the compounds (potency), which was in perfect correlation with the literature.

cAMP Gs dynamic
DOR AntagonistsNaltrindoleNaloxoneNaltrindoleNaloxone
Optimal Cells density / well600060001200012000
IC50 (nM)1.48682.4934
Naltrindole and Naxolone inhibition dose response Delta Opoid receptor

Structure, function and pharmacology of G protein-coupled receptors: State-of-the-art and future challenges

In collaboration with the Faculty of health and medical sciences Denmark - Scientific Presentations

IP-One & cAMP HTRF Functional Cell-based Screening

In collaboration with Schering AG - Scientific Presentations

Biomarker and Cell Signaling Assays for Fibrosis and NASH

HTRF and Alpha solutions for NASH - Flyers

GPCR research from A to Z

HTRF products and supporting scientific content to investifgate GPCRs - Flyers

Application of Bioassay Performance Monitoring Process with Statistical Tools

In collaboration with Amylin Pharmaceuticals Inc., Biocon Limited - Posters

Characterisation of Inositol Phosphate & cAMP Signalling from GPCRs using HTRF

In collaboration with College of Science, King Saud University, University of Western Australia - Posters

HTRF® technology on the SpectraMax® i3 Multi-Mode Platform

In collaboration with Mollecular Devices - Posters

Ultimate guides to master Gs and Gi GPCR assays

Optimizing cAMP assays has never been easier - Guides

Understanding GPCRs is the key to improved DD

In collaboration with GEN - Guides

Identification and characterization of novel positive allosteric modulators of the Dopamine D1 Receptor

Identifying therapeutic candidates for Schizophrenia through HTS - Posters

How to run a cAMP HTRF assay

What to expect at the bench - Videos

Product Insert cAMP Gi / 62AM9PEB-62AM9PEC-62AM9PEJ

62AM9PEB-62AM9PEC-62AM9PEJ - Product Insert

HTRF Product Catalog

All your HTRF assays in one document! - Catalog

A guide to Homogeneous Time Resolved Fluorescence

General principles of HTRF - Guides

How HTRF compares to Western Blot and ELISA

Get the brochure about technology comparison. - Brochures

Immuno-Oncology Drug Discovery

Explore our solutions for Immuno-oncology research - Flyers

Molecular basis of neuroinflammation and neurodegeneration diseases

The essential guide for extending your knowledge on the molecular mechanisms of neurodegenerative diseases - Guides

Neurodegeneration and its main related diseases

Discover this infographic design on neurodegenerative diseases - Infographics

GPCRs Pharmacology

A comprehensive overview of pharmacology's main ligands - Guides

GTP binding assay : Gαi agonist and antagonist guides

Discover how to get the most out of your Gαi agonist and antagonist research with our HTRF GTP binding assays. - Guides

GPCR compounds identification and pharmacological characterization with GTP Gi binding assay

Characterization of candidate molecules through GTP binding assays - Application Notes

GPCR in Cardiovascular Research: The Relevance of Camp and IP-1 Second Messenger Assays

See how peer researchers monitor GPCR signaling with HTRF - Application Notes

Upstream/Downstream GPCR Readout Monitoring with GTP Gi Binding and cAMP Gi HTRF Assays

Read this note featuring two case studies that demonstrate the relevance of combining upstream (GTP) and downstream (cAMP) readouts for characterizing pharmacological compounds - Application Notes

GPCRs: the pathway to Discovery

Complete solutions for GPCR Drug Discovery - Brochures

Plate Reader Requirement

Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.

Let's find your reader